Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Provided By Globe Newswire
Last update: Mar 23, 2023
SOMERVILLE, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today reported fourth quarter and full year 2022 financial results and provided business updates.
